Viral immunomodulatory proteins: Usurping host genes as a survival strategy

Advances in Experimental Medicine and Biology

Volumn 738, Issue , 2012, Pages 256-276

  Engel, Pablo ^a   Angulo, Ana ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; FC RECEPTOR; IMMUNOMODULATORY PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; PROTEIN IRL11; PROTEIN TRL11; PROTEIN UL111A; PROTEIN UL118; PROTEIN UL119; PROTEIN UL128; PROTEIN UL142; PROTEIN UL144; PROTEIN UL146; PROTEIN UL147; PROTEIN UL18; PROTEIN UL33; PROTEIN UL78; PROTEIN US27; PROTEIN US28; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN FUNCTION; ARTICLE; AUTOIMMUNITY; CYTOMEGALOVIRUS; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; UNIQUE LONG SEQUENCE; UNIQUE SHORT SEQUENCE; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS SURVIVAL;

ADAPTIVE IMMUNITY; ANIMALS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENES, VIRAL; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE;

HUMAN HERPESVIRUS 5;

EID: 84859826294     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-1680-7_15     Document Type: Article

References (151)

1. Shackelton LA, Holmes EC. The evolution of large DNA viruses: combining genomic information ofviruses and their hosts. Trends Microbiol 2004; 12:458-465. (Pubitemid 39286124)
2. Holzerlandt R, Orengo C, Kellam P, et al. Identification of new herpesvirus gene homologs in the human genome. Genome Res 2002; 12:1739-1748. (Pubitemid 35363678)
3. Duffy S, Shackelton LA, Holmes EC. Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 2008; 9:267-276. (Pubitemid 351399833)
4. Davison AJ. Evolution of the herpesviruses. Vet Microbiol 2002; 86:69-88. (Pubitemid 34219150)
5. McGeoch DJ, Rixon FJ, Davison AJ. Topics in herpesvirus genomics and evolution. Virus Res 2006; 117:90-104.
6. Brunovskis P, Kung HJ. Retrotransposition and herpesvirus evolution. Virus Genes 1995; 11:259-270. (Pubitemid 26186016)
7. Kotenko SV, Saccani S, Izotova LS, et al. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 2000; 97:1695-700. (Pubitemid 30118505)
8. Jayawardane G, Russell GC, Thomson J, et al. A captured viral interleukin 10 gene with cellular exon structure. J Gen Virol 2008; 89:2447-2455.
9. Elde NC, Malik HS. The evolutionary conundrum ofpathogen mimicry. Nat Rev Microbiol 2009; 7:787-797.
10. Raftery M, Muller A, Schonrich G. Herpesvirus homologues of cellular genes. Virus Genes 2000; 21(1-2):65-75.
11. McFadden G, Murphy PM. Host-related immunomodulators encoded by poxviruses and herpesviruses. Curr Opin Microbiol 2000; 3:371-378. (Pubitemid 30640362)
12. Mocarski ES, Shenk T, Pass, RF. Cytomegaloviruses. In: Kipe DM, Howley PM eds. Fields Virology. Philadelphia: Lippincott Williams and Wilkins, 2007; 2701-2772.
13. Powers C, DeFilippis V, Malouli D, et al. Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 2008; 325:333-359.
14. Miller-Kittrell M, Sparer TE. Feeling manipulated: cytomegalovirus immune manipulation. Virol J 2009; 6:4.
15. Michelson S. Consequences of human cytomegalovirus mimicry. Hum Immunol 2004; 65:465-475. (Pubitemid 38691129)
16. Stern-Ginossar N, Elefant N, Zimmermann A, et al. Host immune system gene targeting by a viral miRNA. Science 2007; 317:376-381. (Pubitemid 47106378)
17. Gibson W. Structure and formation of the cytomegalovirus virion. Curr Top Microbiol Immunol 2008; 325:187-204.
18. Sinzger C, Digel M, Jahn G. Cytomegalovirus cell tropism. Curr Top Microbiol Immunol 2008; 325:63-83.
19. Krmpotic A, Bubic I, Polic B, et al. Pathogenesis of murine cytomegalovirus infection. Microbes Infect 2003; 5:1263-1277. (Pubitemid 37410260)
20. Davison AJ, Dolan A, Akter P, et al. The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. J Gen Virol 2003; 84:17-28. (Pubitemid 36113546)
21. Cha TA, Tom E, Kemble GW, et al. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 1996; 70:78-83. (Pubitemid 126508771)
22. Chee MS, Bankier AT, Beck S, et al. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol 1990; 154:125-169. (Pubitemid 20151030)
23. Lin A, Xu H, Yan W. Modulation of HLA expression in human cytomegalovirus immune evasion. Cell Mol Immunol 2007; 4:91-98.
24. Hansen TH, Bouvier M. MHC class I antigen presentation: learning from viral evasion strategies. Nat Rev Immunol 2009; 9:503-513.
25. Lopez-Botet M, Angulo A Guma M. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 2004; 63:195-203. (Pubitemid 38297253)
26. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 2008; 8:259-68. (Pubitemid 351432802)
27. Wilkinson GW, Tomasec P, Stanton RJ, et al. Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 2008; 41:206-212.
28. Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 1988; 331:269-272. (Pubitemid 18040595)
29. Browne H, Smith G, Beck S, et al. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 1990; 347:770-772.
30. Fahnestock ML, Johnson JL, Feldman RM, et al. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 1995; 3:583-590.
31. Reyburn HT, Mandelboim O, Vales-Gomez M, et al. The class I MHC homologue ofhuman cytomegalovirus inhibits attack by natural killer cells. Nature 1997; 386:514-517. (Pubitemid 27164080)
32. Leong CC, Chapman TL, Bjorkman PJ, et al. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 1998; 187:1681-1687. (Pubitemid 28235109)
33. Odeberg J, Cerboni C, Browne H, et al. Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand J Immunol 2002; 55:149-161. (Pubitemid 34304554)
34. Prod'homme V, Griffin C, Aicheler RJ, et al. The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1 but activates LIR-1- NK cells. J Immunol 2007; 178:4473-4481. (Pubitemid 46492399)
35. Willcox BE, Thomas LM, Bjorkman PJ. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 2003; 4:913-919. (Pubitemid 37098663)
36. Cosman D, Fanger N, Borges L, et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997; 7:273-282. (Pubitemid 27392018)
37. Chapman TL, Heikeman AP, Bjorkman PJ. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 1999; 11:603-613.
38. Vales-Gomez M, Shiroishi M, Maenaka K, et al. Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2. J Virol 2005; 79:2251-2260. (Pubitemid 40204582)
39. Cerboni C, Achour A, Warnmark A, et al. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j. Eur J Immunol 2006; 36:732-741.
40. Wagner CS, Riise GC, Bergstrom T, et al. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J Immunol 2007; 178:3536-3543. (Pubitemid 46417619)
41. Wagner CS, Ljunggren HG, Achour A. Immune modulation by the human cytomegalovirus-encoded molecule UL18, a mystery yet to be solved. J Immunol 2008; 180:19-24.
42. Wills MR, Ashiru O, Reeves MB, et al. Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol 2005; 175: 7457-7465. (Pubitemid 41713443)
43. Chalupny NJ, Rein-Weston A, Dosch S, et al. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem Biophys Res Commun 2006; 346:175-181. (Pubitemid 43865981)
44. Ashiru O, Bennett NJ, Boyle LH, et al. NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142. J Virol 2009; 83:12345-12354.
45. Rawlinson WD, Farrell HE, Barrell BG. Analysis ofthe complete DNA sequence ofmurine cytomegalovirus. J Virol 1996; 70:8833-8849. (Pubitemid 26378467)
46. Chapman TL, Bjorkman PJ. Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J Virol 1998; 72:460-466. (Pubitemid 28048859)
47. Natarajan K, Hicks A, Mans J, et al. Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol 2006; 358:157-171.
48. Farrell HE, Vally H, Lynch DM, et al. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature 1997; 386:510-514. (Pubitemid 27164079)
49. Kubota A, Kubota S, Farrell HE, et al. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell Immunol 1999; 191:145-151. (Pubitemid 29091849)
50. Cretney E, Degli-Esposti MA, Densley EH, et al. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J Exp Med 1999; 190:435-444.
51. Mans J, Zhi L, Revilleza MJ, et al. Structure and function of murine cytomegalovirus MHC-I-like molecules: how the virus turned the host defense to its advantage. Immunol Res 2009; 43:264-279.
52. Arase H, Mocarski ES, Campbell AE, et al. Direct recognition ofcytomegalovirus by activating and inhibitory NK cell receptors. Science 2002; 296:1323-1326. (Pubitemid 34522789)
53. Voigt V, Forbes CA, Tonkin JN, et al. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci USA 2003; 100:13483-13488. (Pubitemid 37444768)
54. Lodoen M, Ogasawara K, Hamerman JA, et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med 2003; 197:1245-1253. (Pubitemid 36617771)
55. Lodoen MB, Abenes G, Umamoto S, et al. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J Exp Med 2004; 200:1075-1081. (Pubitemid 39431131)
56. Hasan M, Krmpotic A, Ruzsics Z, et al. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J Virol 2005; 79:2920-2930. (Pubitemid 40270570)
57. Krmpotic A, Hasan M, Loewendorf A, et al. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J Exp Med 2005; 201:211-220. (Pubitemid 40189430)
58. Ziegler H, Thale R, Lucin P, et al. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 1997; 6:57-66. (Pubitemid 27130215)
59. Krmpotic A, Messerle M, Crnkovic-Mertens I, et al. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T-cell control in vivo. J Exp Med 1999; 190:1285-1296.
60. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104:487-501. (Pubitemid 32201945)
61. Watts TH. TNF/TNFR family members in costimulation of T-cell responses. Annu Rev Immunol 2005; 23:23-68. (Pubitemid 40563164)
62. Cai G, Freeman GJ. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol Rev 2009; 229:244-258.
63. Rahman MM, McFadden G. Modulation of tumor necrosis factor by microbial pathogens. PLoS Pathog 2006; 2:e4.
64. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat Rev Immunol 2003; 3:36-50. (Pubitemid 37328698)
65. Benedict CA, Butrovich KD, Lurain NS, et al. Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 1999; 162:6967-6970. (Pubitemid 29277660)
66. Sedy JR, Spear PG, Ware CF. Cross-regulation between herpesviruses and the TNF superfamily members. Nat Rev Immunol 2008; 8:861-873.
67. Cheung TC, Humphreys IR, Potter KG, et al. Evolutionarily divergent herpesviruses modulate T-cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci USA 2005; 102:13218-13223. (Pubitemid 41325004)
68. Poole E, King CA, Sinclair JH, et al. The UL144 gene product ofhuman cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism. EMBO J 2006; 25:4390-4399. (Pubitemid 44435236)
69. Lurain NS, Kapell KS, Huang DD, et al. Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J Virol 1999; 73:10040-10050.
70. Watts TH, Gommerman JL. The LIGHT and DARC sides of herpesvirus entry mediator. Proc Natl Acad Sci USA 2005; 102:13365-13366. (Pubitemid 41420852)
71. Pestka S, Krause CD, Sarkar D, et al. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004; 22:929-979. (Pubitemid 38680445)
72. Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765. (Pubitemid 32368050)
73. Slobedman B, Barry PA, Spencer JV, et al. Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol 2009; 83:9618-9629.
74. Hughes AL. Origin and evolution of viral interleukin-10 and other DNA virus genes with vertebrate homologues. J Mol Evol 2002; 54:90-101. (Pubitemid 33132008)
75. Spencer JV, Lockridge KM, Barry PA, et al. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 2002; 76:1285-1292. (Pubitemid 34066432)
76. Chang WL, Baumgarth N, Yu D, et al. Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J Virol 2004; 78:8720-8731. (Pubitemid 39025137)
77. Raftery MJ, Wieland D, Gronewald S, et al. Shaping phenotype, function and survival of dendritic cells by cytomegalovirus-encoded IL-10. J Immunol 2004; 173:3383-3391. (Pubitemid 39142048)
78. Spencer JV, Cadaoas J, Castillo PR, et al. Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology 2008; 374:164-169.
79. Cheung AK, Gottlieb DJ, Plachter B, et al. The role of the human cytomegalovirus UL111A gene in down-regulating CD4 T-cell recognition of latently infected cells: implications for virus elimination during latency. Blood 2009; 114:4128-4137.
80. Jenkins C, Abendroth A, Slobedman B. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 2004; 78:1440-1447. (Pubitemid 38095854)
81. Jenkins C, Garcia W, Abendroth A, et al. Expression ofa human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection. Virology 2008; 370:285-294. (Pubitemid 350192559)
82. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12:121-127. (Pubitemid 30398626)
83. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001; 250:91-104. (Pubitemid 32868689)
84. Mackay CR. Chemokines: immunology's high impact factors. Nat Immunol 2001; 2:95-101.
85. Murphy PM. International Union of Pharmacology. Update on chemokine receptor nomenclature. Pharmacol Rev 2002; 54:227-229. (Pubitemid 34575712)
86. Melchjorsen J, Sorensen LN, Paludan SR. Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J Leukoc Biol 2003; 74:331-343. (Pubitemid 38040393)
87. Murphy PM. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2001; 2:116-122. (Pubitemid 33707928)
88. Comerford I, Nibbs RJ. Post-translational control of chemokines: a role for decoy receptors? Immunol Lett 2005; 96:163-174. (Pubitemid 39600772)
89. Saederup N, Mocarski ES Jr. Fatal attraction: cytomegalovirus-encoded chemokine homologs. Curr Top Microbiol Immunol 2002; 269:235-256. (Pubitemid 34851536)
90. Penfold ME, Dairaghi DJ, Duke GM, et al. Cytomegalovirus encodes a potent alpha chemokine. Proc Natl Acad Sci USA 1999; 96:9839-9844. (Pubitemid 29398819)
91. Hahn G, Revello MG, Patrone M, et al. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 2004; 78:10023-10033. (Pubitemid 39187120)
92. Arav-Boger R, Foster CB, Zong JC, et al. Human cytomegalovirus-encoded alpha -chemokines exhibit high sequence variability in congenitally infected newborns. J Infect Dis 2006; 193:788-791.
93. Miller-Kittrell M, Sai J, Penfold M, et al. Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV). Virology 2007; 364:454-465. (Pubitemid 46873706)
94. Alcendor DJ, Zong J, Dolan A, et al. Patterns of divergence in the vCXCL and vGPCR gene clusters in primate cytomegalovirus genomes. Virology 2009; 395:21-32.
95. Akter P, Cunningham C, McSharry BP, et al. Two novel spliced genes in human cytomegalovirus. J Gen Virol 2003; 84:1117-1122. (Pubitemid 36592604)
96. Gerna G, Percivalle E, Lilleri D, et al. Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8 T-cells. J Gen Virol 2005; 86:275-284. (Pubitemid 40227938)
97. Baldanti F, Paolucci S, Campanini G, et al. Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates. Arch Virol 2006; 151:1225-1233. (Pubitemid 43806822)
98. Sun ZR, Ji YH, Ruan Q, et al. Structure characterization of human cytomegalovirus UL131A, UL130 and UL128 genes in clinical strains in China. Genet Mol Res 2009; 8:1191-1201.
99. Fleming P, Davis-Poynter N, Degli-Esposti M, et al. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J Virol 1999; 73:6800-6809. (Pubitemid 29327863)
100. Saederup N, Lin YC, Dairaghi DJ, et al. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc Natl Acad Sci USA 1999; 96:10881-10886. (Pubitemid 29442238)
101. Saederup N, Aguirre SA, Sparer TE, et al. Murine cytomegalovirus CC chemokine homolog MCK-2 (ml3l-l29) is a determinant of dissemination that increases inflammation at initial sites of infection. J Virol 2001; 75:9966-9976. (Pubitemid 32900131)
102. Haggerty SM, Schleiss MR. A novel CC-chemokine homolog encoded by guinea pig cytomegalovirus. Virus Genes 2002; 25:271-279. (Pubitemid 35454580)
103. Arvanitakis L, Geras-Raaka E, Varma A, et al. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 1997; 385:347-350.
104. Casarosa P, Bakker RA, Verzijl D, et al. Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J Biol Chem 2001; 276:1133-1137. (Pubitemid 32096538)
105. Waldhoer M, Kledal TN, Farrell H, et al. Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol 2002; 76:8161-8168. (Pubitemid 34809070)
106. Casarosa P, Gruijthuijsen YK, Michel D, et al. Constitutive signaling ofthe human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi and Gs classes. J Biol Chem 2003; 278:50010-50023. (Pubitemid 37548837)
107. Gao JL, Murphy PM. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J Biol Chem 1994; 269:28539-28542. (Pubitemid 24366680)
108. Kuhn DE, Beall CJ, Kolattukudy PE. The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. Biochem Biophys Res Commun l995; 211:325-330.
109. Kledal TN, Rosenkilde MM, Schwartz TW. Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett 1998; 441:209-214. (Pubitemid 29027897)
110. Casarosa P, Waldhoer M, LiWang PJ, et al. CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor. J Biol Chem 2005; 280:3275-3285. (Pubitemid 40223789)
111. Bodaghi B, Jones TR, Zipeto D, et al. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 1998; 188:855-866. (Pubitemid 28433412)
112. Fraile-Ramos A, Kledal TN, Pelchen-Matthews A, et al. The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling. Mol Biol Cell 2001; 12:1737-1749. (Pubitemid 33049726)
113. Streblow DN, Soderberg-Naucler C, Vieira J, et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 1999; 99:511-520.
114. Rosenkilde MM, Smit MJ, Waldhoer M. Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors. Br J Pharmacol 2008; 153 Suppl 1:S154-S166. (Pubitemid 351341013)
115. Maussang D, Verzijl D, van Walsum M, et al. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci USA 2006; 103:13068-13073. (Pubitemid 44338917)
116. Pleskoff O, Treboute C, Brelot A, et al. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 1997; 276:1874-1878. (Pubitemid 27443667)
117. Pleskoff O, Treboute C, Alizon M. The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins. J Virol 1998; 72:6389-6397. (Pubitemid 28323950)
118. Fraile-Ramos A, Pelchen-Matthews A, Kledal TN, et al. Localization of HCMV UL33 and US27 in endocytic compartments and viral membranes. Traffic 2002; 3:2l8-232.
119. Waldhoer M, Kledal TN, Farrell H, et al. Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol 2002; 76:8161-8168. (Pubitemid 34809070)
120. Margulies BJ, Gibson W. The chemokine receptor homologue encoded by US27 ofhuman cytomegalovirus is heavily glycosylated and is present in infected human foreskin fibroblasts and enveloped virus particles. Virus Res 2007; 123:57-71. (Pubitemid 44751917)
121. Vischer HF, Leurs R, Smit MJ. HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networks. Trends Pharmacol Sci 2006; 27:56-63. (Pubitemid 43063125)
122. Mellado M, Vila-Coro AJ, Martinez C, et al. Receptor dimerization: a key step in chemokine signaling. Cell Mol Biol (Noisy-le-grand) 2001; 47:575-582.
123. Margulies BJ, Browne H, Gibson W. Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology 1996; 225:111-125. (Pubitemid 26390057)
124. Beisser PS, Lavreysen H, Bruggeman CA, et al. Chemokines and chemokine receptors encoded by cytomegaloviruses. Curr Top Microbiol Immunol 2008; 325:221-242.
125. Davis-Poynter NJ, Lynch DM, Vally H, et al. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J Virol 1997; 71:1521-1529. (Pubitemid 27030328)
126. Beisser PS, Vink C, Van Dam JG, et al. The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. J Virol 1998; 72:2352-2363. (Pubitemid 28100796)
127. Case R, Sharp E, Benned-Jensen T, et al. Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo. J Virol 2008; 82:1884-1898. (Pubitemid 351222436)
128. Melnychuk RM, Smith P, Kreklywich CN, et al. Mouse cytomegalovirus M33 is necessary and sufficient in virus-induced vascular smooth muscle cell migration. J Virol 2005; 79:10788-10795. (Pubitemid 41098617)
129. Beisser PS, Grauls G, Bruggeman CA, et al. Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain. J Virol 1999; 73:7218-7230. (Pubitemid 29383203)
130. Oliveira SA, Shenk TE. Murine cytomegalovirus M78 protein, a G protein-coupled receptor homologue, is a constituent of the virion and facilitates accumulation of immediate-early viral mRNA. Proc Natl Acad Sci USA 2001; 98:3237-3242. (Pubitemid 32220829)
131. Milne RS, Mattick C, Nicholson L, et al. RANTES binding and down-regulation by a novel human herpesvirus-6 beta chemokine receptor. J Immunol 2000; 164:2396-2404. (Pubitemid 30115467)
132. Tadagaki K, Nakano K, Yamanishi K. Human herpesvirus 7 open reading frames U12 and U51 encode functional beta-chemokine receptors. J Virol 2005; 79:7068-7076. (Pubitemid 40677338)
133. Fitzsimons CP, Gompels UA, Verzijl D, et al. Chemokine-directed trafficking of receptor stimulus to different g proteins: selective inducible and constitutive signaling by human herpesvirus 6-encoded chemokine receptor U51. Mol Pharmacol 2006; 69:888-898. (Pubitemid 43363863)
134. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991; 9:457-492.
135. Frey J, Einsfelder B. Induction of surface IgG receptors in cytomegalovirus-infected human fibroblasts. Eur J Biochem 1984; 138:213-216. (Pubitemid 14216584)
136. Stannard LM, Hardie DR. An Fc receptor for human immunoglobulin G is located within the tegument of human cytomegalovirus. J Virol 1991; 65:3411-3415.
137. Lilley BN, Ploegh HL, Tirabassi RS. Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol 2001; 75:11218-11221. (Pubitemid 33031588)
138. Atalay R, Zimmermann A, Wagner M, et al. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 2002; 76:8596-8608. (Pubitemid 34864054)
139. Thale R, LucinP, Schneider Ket al. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol 1994; 68:7757-7765. (Pubitemid 24362662)
140. Crnkovic-Mertens I, Messerle M, Milotic I, et al. Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. J Virol 1998; 72:1377-1382. (Pubitemid 28116923)
141. Lenac T, Budt M, Arapovic J, et al. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med 2006; 203:1843-1850. (Pubitemid 44188458)
142. Arapovic J, Lenac Rovis T, et al. Promiscuity of MCMV immunoevasin of NKG2D: m138/fcr-1 down-modulates RAE-1epsilon in addition to MULT-1 and H60. Mol Immunol 2009; 47:114-122.
143. Mintern JD, Klemm EJ, Wagner M, et al. Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. J Immunol 2006; 177:8422-8431. (Pubitemid 44893804)
144. Fujinami RS, Oldstone MB. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985; 230:1043-1045. (Pubitemid 16192692)
145. Fujinami RS, von Herrath MG, Christen U, et al. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 2006; 19:80-94. (Pubitemid 43157648)
146. Munz C, Lunemann JD, Getts MT, et al. Antiviral immune responses: triggers ofor triggered by autoimmunity? Nat Rev Immunol 2009; 9:246-258.
147. Lunardi C, Bason C, Navone R, et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000; 6:1183-1186.
148. Lunardi C, Dolcino M, Peterlana D, et al. Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS Med 2006; 3:e2.
149. Bason C, Corrocher R, Lunardi C, et al. Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 2003; 362:1971-1977. (Pubitemid 37548421)
150. von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 2003; 1:151-157.
151. Novotny J, Rigoutsos I, Coleman D, et al. In silico structural and functional analysis of the human cytomegalovirus (HHV5) genome. J Mol Biol 2001; 310:1151-1166. (Pubitemid 32738384)